08/18/2025 8:28 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
08/18/2025 8:29 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
08/18/2025 8:29 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
08/18/2025 7:31 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2025 8:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2025 4:23 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/18/2025 4:23 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/18/2025 4:23 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/27/2025 4:15 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/27/2025 4:16 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/27/2025 4:16 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for BDRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
06/13/2025 3:19 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2025 4:23 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/02/2025 4:24 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/30/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025 4:59 PM | Biodexa Pharmaceuticals (Subject) C/M CAPITAL PARTNERS, LP (Filed by)
| Form SCHEDULE 13G | |
05/22/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2025 4:16 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/15/2025 4:16 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/12/2025 7:31 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/11/2025 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/11/2025 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/11/2025 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
05/12/2025 5:02 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/12/2025 5:02 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
05/12/2025 5:02 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
04/29/2025 3:15 PM | Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
04/17/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2025 7:41 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2025 7:43 AM | Biodexa Pharmaceuticals (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/10/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 3:30 PM | Biodexa Pharmaceuticals (Subject) C/M CAPITAL PARTNERS, LP (Filed by)
| Form SCHEDULE 13G | |
02/13/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/10/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025 11:15 PM | Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
01/28/2025 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/22/2025 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buffett to put 90% of his money in this one stock? (Ad) CPA and CFA says you have WAY too many stocks - just buy these 3
After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%. Click here to view… |
01/21/2025 5:27 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:18 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:21 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:24 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/21/2025 5:15 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/17/2025 3:49 PM | Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
01/17/2025 3:21 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:03 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:06 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:09 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:15 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
01/08/2025 5:18 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/27/2024 4:15 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024 10:56 AM | Biodexa Pharmaceuticals (Subject) Brio Capital Master Fund Ltd. (Filed by)
| Form SC 13G/A | |
11/05/2024 5:09 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:15 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:06 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:06 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:00 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/05/2024 5:03 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
11/01/2024 4:18 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/16/2024 8:12 AM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
10/15/2024 4:14 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2024 7:30 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/27/2024 3:41 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/26/2024 7:42 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/20/2024 3:36 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
Buffett to put 90% of his money in this one stock? (Ad) CPA and CFA says you have WAY too many stocks - just buy these 3
After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%. Click here to view… |
09/19/2024 3:30 PM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 7:40 AM | Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
09/06/2024 6:54 PM | Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |